Ameriprise
OPTR

Ameriprise’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Ameriprise’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-111,103
Closed -$1.4M – 5804
2013
Q3 		$1.4M Buy
111,103
+96,203
+646% +$1.27M ﹤0.01% 2579
2013
Q2 		$216K Buy
+14,900
New +$217K ﹤0.01% 3060

Ameriprise's OPTR Position: Q4 2013 in Review

Ameriprise sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 111,103 shares — an estimated $1.4M sold.

Ameriprise first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $1.4M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Ameriprise reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Ameriprise sold 111,103 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $1.4M.
  • Ameriprise first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Ameriprise's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $1.4M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Ameriprise's 13F filing for Q4 2013, filed 14 Feb 2014.